Acurx Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $7.6M | $3.7M | $7.5M | $9.1M | $13.0M | $3.2M | $2.5M |
| Accounts Receivable | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | — | — | — | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — |
| Total Assets | $7.7M | $3.9M | $7.7M | $9.4M | $13.3M | $3.2M | — |
| Liabilities | |||||||
| Accounts Payable | — | — | — | — | — | — | — |
| Total Current Liabilities | $2.4M | $3.2M | $3.0M | $2.1M | $843.9K | $472.6K | — |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $2.4M | $3.2M | $3.0M | $2.1M | $843.9K | $522.4K | — |
| Stockholders' Equity | |||||||
| Retained Earnings | $-75.3M | $-67.3M | $-53.2M | $-38.6M | $-26.5M | $-13.8M | — |
| Total Stockholders' Equity | $5.3M | $615.1K | $4.7M | $7.3M | $12.4M | $2.7M | — |